Medtronic plc (LON:0Y6X)
Market Cap | 93.07B |
Revenue (ttm) | 25.45B |
Net Income (ttm) | 3.47B |
Shares Out | n/a |
EPS (ttm) | 2.69 |
PE Ratio | 26.84 |
Forward PE | 16.83 |
Dividend | 2.14 (2.18%) |
Ex-Dividend Date | Sep 26, 2025 |
Volume | 3,064 |
Average Volume | 4,181 |
Open | 98.00 |
Previous Close | 98.17 |
Day's Range | 96.03 - 98.29 |
52-Week Range | 79.31 - 100.00 |
Beta | 0.79 |
RSI | 56.38 |
Earnings Date | Nov 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic plc (MDT) Special Call - Slideshow
Medtronic Plc (MDT) Altaviva Device Management Call Transcript
Medtronic plc - Special Call
Medtronic plc - Special CallCompany ParticipantsRyan Weispfenning - VP & Head of Investor RelationsEmily ElswickConference Call ParticipantsRyan...
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News
November 28th Options Now Available For Medtronic (MDT)
Investors in Medtronic PLC (Symbol: MDT) saw new options begin trading today, for the November 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDT options ...

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
TIME Best Inventions honors extraordinary innovations changing lives DUBLIN , Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Bra...

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart disease Orchestra BioMed and Medtronic (NYSE:...

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women
Medtronic announces U.S. clinical ... Full story available on Benzinga.com
Medtronic (MDT) Launches Clinical Study for Robotic Surgery System
Medtronic (MDT) Launches Clinical Study for Robotic Surgery System

Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY...
Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News
Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News
Medtronic (MDT) Announces Successful â¬1.5 Billion Notes Offering
Medtronic (MDT) Announces Successful â¬1.5 Billion Notes Offering

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY , Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public ...
Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Medtronic (MDT) stood at $94.3, denoting a -1.5% move from the preceding trading day.

Medtronic: FY26 Outlook Strengthened By New Product Launches
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...

Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Medtronic plc (NYSE:MDT) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g...

1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today
Medtronic is one of the largest medical device makers in the world, and it is focused on getting more profitable.
Medtronic (MDT) Shares Cross 3% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Medtronic PLC (Symbol: MDT) were yielding above the 3% mark based on its quarterly dividend (annualized ...
FDA Greenlights Medtronic's (MDT) Bladder Control Device
FDA Greenlights Medtronic's (MDT) Bladder Control Device
Strategy To YieldBoost Medtronic To 9.9% Using Options
Shareholders of Medtronic PLC (Symbol: MDT) looking to boost their income beyond the stock's 3% annualized dividend yield can sell the March 2026 covered call at the $100 strike and collect the premiu...

Medtronic gets FDA nod for the Altaviva device
Medtronic’s Altaviva bladder control device earns FDA approval for urge urinary incontinence. Read more here.
Medtronic (MDT) Gains FDA Approval for Altaviva Device
Medtronic (MDT) Gains FDA Approval for Altaviva Device

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.